Fabino Life Sciences Ltd
BSE: 543444
P/L Snapshot
Q2 FY26 · standalone
vs Q4 FY25·vs Q2 FY25
Revenue
0.83
-94.1%-81.0%
Expenditure
1.07
-92.2%-75.1%
Net Profit
-0.25
-392.9%-629.8%
OPM %
-77.35%
-76.62pp-74.41pp
Shareholding
Pattern breakdown
P/L Trends
(in crores)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingFABINO
202612Oct
Board Meeting
The Board of Directors approved the alteration of the Main O…
BSE Filing ↗ Board MeetingFABINO
202629Sep
Board Meeting
The Board of Directors approved the appointment of Mr. Samr…
BSE Filing ↗ Board MeetingFABINO
20264Sep
Board Meeting
The Board of Directors considered and approved the re-appoin…
BSE Filing ↗ Board MeetingFABINO
202623May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingFABINO
202421Oct
Board Meeting
Intimation Of Board Meeting For Consideration And Approval O…
BSE Filing ↗ Board MeetingFABINO
202428May
Board Meeting
Consideration and Approval of Audited Financial Results (sta…
BSE Filing ↗